Stephen Globus
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
Stephen Globus is a
vaccine to treat lymphoma
.
Globus also was founder and chairman of PlasmaCoMatsushita (Panasonic) in 1996. Globus was on the Japanese Board of Directors for the proceeding 7 years after the sale. His other ventures activities include key investment or managerial roles in Proscure (sold to Repligen), ExSar, Kimeragen which sold to a Paris-based company whose board Globus served on, Energy Research (Fuel Cell Energy), Nematron, and Tinsley Laboratories which developed the optic correction for Hubble Space Telescope now a division of the Dutch company ASML.
Globus holds
China Institute in America
.
References
- ISBN 9781118311967. Retrieved 5 July 2012.